Source: CURATED
Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
sodium voltage-gated channel alpha subunit 10 | 0.566 | 0.692 | 9.9E-38 |
|
disease | 0.800 | disputed | 0.929 | 9 | 13 | 1998 | 2019 | ||||||||
|
transient receptor potential cation channel subfamily M member 4 | 0.633 | 0.577 | 5.7E-33 |
|
disease | 0.530 | disputed | 1.000 | 7 | 0 | 2012 | 2018 | ||||||||
|
plakophilin 2 | 0.606 | 0.538 | 3.1E-18 |
|
disease | 0.650 | disputed | 1.000 | 10 | 0 | 1996 | 2016 | ||||||||
|
A-kinase anchoring protein 9 | 0.638 | 0.385 | 4.5E-17 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2014 | 2019 | ||||||||
|
ATP binding cassette subfamily C member 9 | 0.552 | 0.692 | 9.4E-09 |
|
disease | 0.510 | None | 1.000 | 1 | 0 | 2014 | 2016 | ||||||||
|
calcium voltage-gated channel auxiliary subunit beta 2 | 0.659 | 0.538 | 2.7E-06 |
|
disease | 0.510 | disputed | 1.000 | 7 | 0 | 2000 | 2012 | ||||||||
|
RAN guanine nucleotide release factor | 0.751 | 0.231 | 2.4E-05 |
|
disease | 0.550 | disputed | 0.889 | 6 | 0 | 2008 | 2019 | ||||||||
|
sodium voltage-gated channel beta subunit 2 | 0.678 | 0.192 | 1.7E-03 |
|
disease | 0.510 | disputed | 1.000 | 5 | 0 | 2009 | 2016 | ||||||||
|
glycerol-3-phosphate dehydrogenase 1 like | 0.674 | 0.308 | 3.8E-02 |
|
disease | 0.360 | disputed | 0.833 | 3 | 0 | 2007 | 2018 | ||||||||
|
sodium voltage-gated channel beta subunit 3 | 0.686 | 0.269 | 5.1E-02 |
|
disease | 0.530 | disputed | 0.917 | 11 | 0 | 2001 | 2016 | ||||||||
|
sodium voltage-gated channel beta subunit 1 | 0.575 | 0.538 | 0.10 |
|
disease | 0.550 | disputed | 1.000 | 7 | 0 | 2008 | 2019 | ||||||||
|
potassium voltage-gated channel subfamily E regulatory subunit 5 | 0.666 | 0.500 | 0.12 |
|
disease | 0.620 | disputed | 1.000 | 5 | 0 | 1999 | 2019 | ||||||||
|
potassium inwardly rectifying channel subfamily J member 8 | 0.619 | 0.538 | 0.38 |
|
disease | 0.520 | disputed | 1.000 | 6 | 0 | 2002 | 2014 | ||||||||
|
potassium voltage-gated channel subfamily E regulatory subunit 3 | 0.666 | 0.423 | 0.47 |
|
disease | 0.510 | disputed | 1.000 | 4 | 0 | 2005 | 2012 | ||||||||
|
hes related family bHLH transcription factor with YRPW motif 2 | 0.572 | 0.731 | 0.89 |
|
disease | 0.350 | None | 0.800 | 1 | 0 | 2013 | 2019 | ||||||||
|
sodium voltage-gated channel alpha subunit 5 | 0.513 | 0.654 | 0.91 |
|
disease | 1.000 | definitive | 0.984 | 26 | 102 | 1995 | 2020 | ||||||||
|
calmodulin 2 | 0.472 | 0.808 | 0.92 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
potassium voltage-gated channel subfamily D member 3 | 0.619 | 0.615 | 0.99 |
|
disease | 0.560 | disputed | 1.000 | 5 | 0 | 1999 | 2019 | ||||||||
|
potassium voltage-gated channel subfamily H member 2 | 0.522 | 0.731 | 1.00 |
|
disease | 0.450 | disputed | 1.000 | 6 | 1 | 2002 | 2020 | ||||||||
|
hyperpolarization activated cyclic nucleotide gated potassium channel 4 | 0.617 | 0.269 | 1.00 |
|
disease | 0.320 | disputed | 1.000 | 4 | 0 | 2004 | 2019 | ||||||||
|
sarcolemma associated protein | 0.686 | 0.462 | 1.00 |
|
disease | 0.510 | disputed | 1.000 | 4 | 0 | 1997 | 2012 | ||||||||
|
calcium voltage-gated channel auxiliary subunit alpha2delta 1 | 0.641 | 0.500 | 1.00 |
|
disease | 0.620 | disputed | 1.000 | 6 | 0 | 2005 | 2015 | ||||||||
|
calcium voltage-gated channel subunit alpha1 C | 0.510 | 0.846 | 1.00 |
|
disease | 0.570 | disputed | 1.000 | 7 | 0 | 1993 | 2019 | ||||||||
|
ankyrin 2 | 0.626 | 0.538 | 1.00 |
|
disease | 0.300 | disputed | 1.000 | 4 | 0 | 2004 | 2016 |